Rocket Lab Is Launching Faster Than Ever — So Why Is Its Stock Crashing?
28.06.2026 - 04:03:16 | boerse-global.de
Rocket Lab has never been busier — or more punished by the market. The company just pulled off a record-breaking 16-hour-and-42-minute launch turnaround for the U.S. Space Force, secured three new NASA Electron contracts, and posted the highest quarterly revenue in its history. Yet in the span of a single week, the stock shed more than 22% of its value, and it now sits roughly 46% below the 52-week high of €133.80 reached on May 27. At €72.70, the disconnect between operational momentum and market sentiment has rarely been wider.
Three converging headwinds explain the rout — and they feed off each other. The most immediate is a $3 billion at-the-market equity offering that has spooked investors with dilution fears. That anxiety is amplified by the long-awaited initial public offering of SpaceX, which is siphoning capital out of the broader space sector. Adding to the unease, insider net selling totaled $41 million over the past twelve months — a signal that even those closest to the business are cashing out.
The Nasdaq-100 inclusion, initially hailed as a structural catalyst, turned into a textbook sell-the-news event. Instead of stabilizing the stock, the index entry coincided with a drop of more than 10%. Automatic index-fund buying may provide a floor over time, but for now it has failed to stem the slide.
The operational story, however, remains compelling
Rocket Lab’s first quarter of 2026 delivered record revenue of $200.3 million, a 63.5% year-over-year surge. GAAP gross margin widened to 38.2%, and the order backlog swelled to $2.2 billion — up 20% from the prior quarter and representing work extending into 2029. The company expects second-quarter revenue of between $225 million and $240 million, with earnings due on August 6.
Should investors sell immediately? Or is it worth buying Rocket Lab?
That backlog got another boost on June 25, when NASA awarded Rocket Lab three new Electron launches. Two are for the PolSIR mission, scheduled for June 2027 and designed to study ice clouds in tropical and subtropical regions. The third will carry the TSIS-2 solar instrument, targeting an early 2027 lift-off from the company’s New Zealand complex. These join previously contracted missions for the Aspera and LOXSAT payloads, with LOXSAT marking Rocket Lab’s first demonstration of in-space refueling using its Photon spacecraft.
Launch cadence has also accelerated. The June 26 flight from New Zealand — the tenth consecutive mission for Japanese Earth-observation client Synspective, all successful — was Rocket Lab’s 12th start of 2026 and the 91st overall for the Electron vehicle. The company now produces one rocket every 11 days, a pace that enables rapid-response missions such as VICTUS HAZE, where the Space Force order-to-liftoff interval was slashed to under 17 hours.
Technicals and analyst sentiment
Despite the slide, the relative strength index (RSI) has fallen to 35.3, territory that typically signals an oversold condition. The next key support level is the 200-day moving average at €65.21. On a 12-month basis, shareholders are still sitting on a gain of roughly 136%, a reminder of how far the stock had run before the correction.
Analyst conviction remains largely intact. Fifteen of the 19 analysts covering Rocket Lab maintain a buy rating. KeyBanc upgraded the stock to "Overweight" with a $135 price target, pointing to structurally constrained launch supply versus growing satellite demand — a dynamic that should benefit Rocket Lab regardless of near-term volatility.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
The Neutron wild card
The biggest catalyst on the horizon is the Neutron rocket, designed for heavier payloads and eventual profitability. A tank test failure early in the year pushed the maiden flight to at least the fourth quarter of 2026. Engine tests are ongoing, and a landing platform is under construction. Every update on Neutron’s development is likely to move the stock — in either direction.
But even a successful debut won’t erase the valuation risk. At a price-to-sales ratio of 45, with revenue growth forecast at 41%, Rocket Lab leaves little room for disappointment. The company can keep setting records from its New Zealand launch pad, but until the market sees a path through dilution, sector competition, and insider selling, the share price may continue to feel the gravity of those forces.
Ad
Rocket Lab Stock: New Analysis - 28 June
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
